UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. Click ...

Once thought to be doomed by the AI revolution, robotic process automation specialist UiPath (NYSE: PATH) defied critics in ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

NEW YORK--(BUSINESS WIRE)-- UiPath (NYSE: PATH), a global leader in agentic automation, today announced it has become a founding technical contributor to AIUC-1, the leading security framework for AI ...

In the modern era, artificial intelligence continues to revolutionize industries and reshape the global economy. As investors scout for promising opportunities in the AI sector, two names frequently ...

There may be no enterprise job today that can’t be enhanced through the use of automation and AI, and agentic AI represents the next step toward fully realizing that potential. So says Daniel Dines, ...

Palantir is growing like a weed, but its valuations are getting overheated. UiPath faces tough near-term challenges, but its stock looks a lot cheaper. Both stocks are risky plays in this frothy ...

Business automation software company UiPath Inc. beat expectations for its third-quarter financial results today and followed up with strong guidance for the current quarter. The company reported ...

Palantir has been one of the best growth stories in the market. UiPath is just beginning to see its revenue growth accelerate as it looks to become an AI agent orchestration platform. UIPath's ...

Asia-Pacific enterprises are rapidly advancing AI adoption, with investments expected to grow from nearly US$90 billion in 2025 to US$176 billion by 2028, primarily focused on building agentic AI ...